Evaluation of a transgenic mouse model of multiple sclerosis with noninvasive methods

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 5, 2011, Pages 2405-2411

  Enriquez Algeciras, Mabel ^a   Ding, Di ^a,b   Chou, Tsung Han ^a   Wang, Jianhua ^a   Padgett, Kyle R ^b   Porciatti, Vittorio ^a   Bhattacharya, Sanjoy K ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; CLINICAL ASSESSMENT; CONTROLLED STUDY; ELECTROPHYSIOLOGY; ELECTRORETINOGRAM; EVALUATION; GAIT DISORDER; HISTOLOGY; MOUSE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NON INVASIVE MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE DISEASE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; FEMALE; GENOTYPE; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, TRANSGENIC; MULTIPLE SCLEROSIS; TOMOGRAPHY, OPTICAL COHERENCE; VISION DISORDERS; VISUAL PATHWAYS;

EID: 79955980970     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-6425     Document Type: Article

References (31)

1. Trapp BD, Nave KA. Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci. 2008;31:247-269.
2. Ziemssen, T. Modulating processes within the central nervous system is central to therapeutic control of multiple sclerosis. J Neurol. 2005;252(suppl 5):v38-v45.
3. Gallo V, Armstrong RC. Myelin repair strategies: a cellular view. Curr Opin Neurol. 2008;21:278-283.
4. Libbey JE, McCoy LL, Fujinami RS. Molecular mimicry in multiple sclerosis. Int Rev Neurobiol. 2007;79:127-147.
5. Denic A, Johnson AJ, Bieber AJ, Warrington AE, Rodriguez M, Pirko I. The relevance of animal models in multiple sclerosis research. Pathophysiology. 2011;18:21-29.
6. Hart BA, Laman JD, Bauer J, Blezer E, van Kooyk Y, Hintzen RQ. Modelling of multiple sclerosis: lessons learned in a non-human primate. Lancet Neurol. 2004;3:588-597.
7. Rose NR. Avian models of autoimmune disease: lessons from the birds. Poult Sci. 1994;73:984-990.
8. Kinutani M, Coltey M, Le Douarin NM. Postnatal development of a demyelinating disease in avian spinal cord chimeras. Cell. 1986;45: 307-314.
9. Mix E, Meyer-Rienecker H, Zettl UK. Animal models of multiple sclerosis for the development and validation of novel therapies-potential and limitations. J Neurol. 2008;255(suppl 6):7-14.
10. Schreiner B, Heppner FL, Becher B. Modeling multiple sclerosis in laboratory animals. Semin Immunopathol. 2009;31:479-495.
11. Kolappan M, Henderson AP, Jenkins TM, et al. Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis. J Neurol. 2009;256:305-319.
12. Beeton C, Garcia A, Chandy KG. Induction and clinical scoring of chronic-relapsing experimental autoimmune encephalomyelitis. J Vis Exp. 2007:224.
13. Safran AB. Late onset multiple sclerosis: clinical pattern of optic nerve involvement. Metab Pediatr Syst Ophthalmol. 1989;12:58-60.
14. Holder GE, Gale RP, Acheson JF, Robson AG. Electrodiagnostic assessment in optic nerve disease. Curr Opin Neurol. 2009;22:3-10.
15. Pula JH, Reder AT. Multiple sclerosis, I: neuro-ophthalmic manifestations. Curr Opin Ophthalmol. 2009;20:467-475.
16. Kallenbach K, Frederiksen J. Optical coherence tomography in optic neuritis and multiple sclerosis: a review. Eur J Neurol. 2007;14:841-849.
17. Bodis-Wollner I. Sensory evoked potentials: PERG, VEP, and SEP. Curr Opin Neurol Neurosurg. 1992;5:716-726.
18. Johnson RS, Roder JC, Riordan JR. Over-expression of the DM-20 myelin proteolipid causes central nervous system demyelination in transgenic mice. J Neurochem. 1995;64:967-976.
19. Mastronardi FG, Ackerley CA, Arsenault L, Roots BI, Moscarello MA. Demyelination in a transgenic mouse: a model for multiple sclerosis. J Neurosci Res. 1993;36:315-324.
20. Porciatti V. The mouse pattern electroretinogram. Doc Ophthalmol. 2007;115:145-153.
21. Ruggeri M, Wehbe H, Jiao S, et al. In vivo three-dimensional high-resolution imaging of rodent retina with spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2007;48: 1808-1814.
22. Mastronardi FG, Min W, Wang H, et al. Attenuation of experimental autoimmune encephalomyelitis and nonimmune demyelination by IFN-beta plus vitamin B12: treatment to modify notch-1/sonic hedgehog balance. J Immunol. 2004;172:6418-6426.
23. Mastronardi FG, Tsui H, Winer S, et al. Synergy between paclitaxel plus an exogenous methyl donor in the suppression of murine demyelinating diseases. Mult Scler. 2007;13:596-609.
24. Blakemore WF, Franklin RJ. Remyelination in experimental models of toxin-induced demyelination. Curr Top Microbiol Immunol. 2008;318:193-212.
25. Bhatti MT, Newman NJ. A multiple sclerosis-like illness in a man harboring the mtDNA 14484 mutation. J Neuroophthalmol. 1999; 19:28-33.
26. Holder GE. Pattern electroretinography (PERG) and an integrated approach to visual pathway diagnosis. Prog Retin Eye Res. 2001; 20:531-561.
27. Mastronardi FG, Ackerley CA, Roots BI, Moscarello MA. Loss of myelin basic protein cationicity in DM-20 transgenic mice is dosage dependent. J Neurosci Res. 1996;44:301-307.
28. Kitagawa K, Sinoway MP, Yang C, Gould RM, Colman DR. A proteolipid protein gene family: expression in sharks and rays and possible evolution from an ancestral gene encoding a pore-forming polypeptide. Neuron. 1993;11:433-448.
29. Saugier-Veber P, Munnich A, Bonneau D, et al. X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat Genet. 1994;6:257-262.
30. Iragavarapu S, Algeciras ME, Lee RK, Bhattacharya SK. ETX1 is over-expressed in the glaucomatous trabecular meshwork. Mol Vis. 2009;15:2061-2067.
31. Wang J, Wang MR, Jiang H, Shen M, Cui L, Bhattacharya SK. Detection of magnetic particles in live DBA/2J mouse eyes using magnetomotive optical coherence tomography. Eye Contact Lens. 2010;36:346-351.